CURIS, INC. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
CURIS, INC. (CRIS) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $32.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2017-11-07
- CURIS, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2017-09-30 was $32.00K.
- CURIS, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2017-06-30 was -$41.00K.
- CURIS, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2017-03-31 was -$60.00K.
- CURIS, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2016-09-30 was -$58.00K.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 6 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 9 month |
|---|---|---|---|
| 2017-09-30 | $32.00K 10-Q · filed 2017-11-07 | -$9.00K derived: sum of 2 quarters · filed 2017-11-07 | -$70.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$41.00K 10-Q · filed 2017-08-03 | -$102.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$60.00K 10-Q · filed 2017-05-04 | ||
| 2016-09-30 | -$58.00K 10-Q · filed 2017-11-07 | -$220.00K derived: sum of 2 quarters · filed 2017-11-07 | -$238.00K 10-Q · filed 2017-11-07 |
| 2016-06-30 | -$162.00K 10-Q · filed 2017-08-03 | -$180.00K 10-Q · filed 2017-08-03 | |
| 2016-03-31 | -$18.00K 10-Q · filed 2017-05-04 | ||
| 2015-09-30 | -$248.00K 10-Q · filed 2016-11-03 | -$199.00K derived: sum of 2 quarters · filed 2016-11-03 | -$212.00K 10-Q · filed 2016-11-03 |
| 2015-06-30 | $49.00K 10-Q · filed 2016-08-04 | $36.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |